Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Cash & Equivalents (2016 - 2025)

Elite Health Systems (EHSI) has disclosed Cash & Equivalents for 16 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 25.12% to $4.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.0 million, a 25.12% increase, with the full-year FY2024 number at $4.0 million, up 765.67% from a year prior.
  • Cash & Equivalents was $4.0 million for Q3 2025 at Elite Health Systems, up from $3.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.0 million in Q4 2024 to a low of $466000.0 in Q4 2023.
  • A 5-year average of $2.1 million and a median of $2.2 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 74.64% in 2022, then soared 765.67% in 2024.
  • Elite Health Systems' Cash & Equivalents stood at $2.2 million in 2021, then fell by 29.43% to $1.5 million in 2022, then crashed by 69.68% to $466000.0 in 2023, then skyrocketed by 765.67% to $4.0 million in 2024, then decreased by 1.59% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for EHSI's Cash & Equivalents are $4.0 million (Q3 2025), $3.1 million (Q2 2025), and $3.7 million (Q1 2025).